Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01016756 · ClinicalTrials.gov registry record
Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 341
- Enrollment target
NCT01016756 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 341 participants.
The verdict
NCT01016756 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 341 participants
- Enrollment target
Study Summary
1. PHACE syndrome(OMIM database number 606519) is the association of a vascular birthmark (hemangioma) on the face along with one or more of the following conditions: congenital heart defects, congenital anomalies of the cerebral arteries,brain, eyes, or sternum. 2. A research study is currently being conducted at the Medical College of Wisconsin (MCW) to investigate if there is an inherited cause of PHACE syndrome. 3. We are hoping that this study will lead to a better understanding of how and why children develop PHACE syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2007-02 |
| Est. Completion | 2022-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01016756
The ClinicalTrials.gov registry entry for NCT01016756 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 341 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01016756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01016756 about?
NCT01016756 is a clinical study titled "Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)". 1. PHACE syndrome(OMIM database number 606519) is the association of a vascular birthmark (hemangioma) on the face along with one or more of the following conditions: congenital heart defects, congenital anomalies of the cerebral arteries,brain, eyes, or sternum. 2. A research study is currently bei...
What is the current status of trial NCT01016756?
This trial is currently completed. The enrollment target is 341 participants. The study started on 2007-02. Estimated completion is 2022-08-15.
Who is sponsoring clinical trial NCT01016756?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.